Assessment of treatment with immunoglobulines in recurrent miscarriage
Cernadas C, Pichon Riviere A, Augustovski F
Record ID 32005000623
Spanish
Authors' objectives:
The aim of this study is to assess the available evidence on treatment with immunoglobulines in recurrent miscarriage.
Authors' results and conclusions:
Treatment with intravenous immunoglobulines to treat this disorder has been evaluated in multiple comparative studies during the last decade. This assessment analyzed relevant studies comparing treatment with intravenous immunoglobulines vs placebo in women with recurrent miscarriages (three miscarriages or more during the first three months of pregnancy).
Authors' recommendations:
Based on the data published in randomized clinical trials and meta-analysis, it can be concluded that this treatment is not effective in terms of recurrent miscarriage prevention, being still in the research stage.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.iecs.org.ar/
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Female
- Pregnancy
- Abortion, Habitual
- Immunoglobulins, Intravenous
- Immunologic Factors
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.